Inventor · disambiguated record
Shui-On Leung
Also filed as: LEUNG SHUI-ON · MCBRIDE WILLIAM J
27 granted patents·20 pending applications·2,775 citations·filing 1993–2024
98Inventor score
Top patents by PatentIndex Score
47 records- 0199US7312318B2Internalizing anti-CD74 antibodies and methods of useIMMUNOMEDICS INC·Filed 2003·Granted Dec 25, 2007·243 cites·23 claims
- 0299US6472511B1Stimulation of an immune response with antibodies labeled with the α-galactosyl epitopeIMMUNOMEDICS INC·Filed 2000·Granted Oct 29, 2002·160 cites·5 claims
- 0398US7541440B2Chimeric, human and humanized anti-granulocyte antibodies and methods of useIMMUNOMEDICS INC·Filed 2003·Granted Jun 2, 2009·129 cites·24 claims
- 0498US6962702B2Production and use of novel peptide-based agents for use with bi-specific antibodiesIMMUNOMEDICS INC·Filed 2001·Granted Nov 8, 2005·126 cites·30 claims
- 0598US6187287B1Immunoconjugates and humanized antibodies specific for B-cell lymphoma and leukemia cellsIMMUNOMEDICS INC·Filed 1998·Granted Feb 13, 2001·402 cites·34 claims
- 0698US5789554AImmunoconjugates and humanized antibodies specific for B-cell lymphoma and leukemia cellsIMMUNOMEDICS INC·Filed 1996·Granted Aug 4, 1998·596 cites·32 claims
- 0798US5443953APreparation and use of immunoconjugatesIMMUNOMEDICS INC·Filed 1993·Granted Aug 22, 1995·338 cites·17 claims
- 0897US7919087B2Internalizing anti-CD74 antibodies and methods of useIMMUNOMEDICS INC·Filed 2007·Granted Apr 5, 2011·33 cites·18 claims
- 0997US6254868B1Glycosylated humanized B-cell specific antibodiesIMMUNOMEDICS INC·Filed 1997·Granted Jul 3, 2001·206 cites·12 claims
- 1096US7138103B2Use of bi-specific antibodies for pre-targeting diagnosis and therapyIMMUNOMEDICS INC·Filed 2002·Granted Nov 21, 2006·65 cites·36 claims
- 1195US5635603APreparation and use of immunoconjugatesIMMUNOMEDICS INC·Filed 1994·Granted Jun 3, 1997·176 cites·12 claims
- 1294US7429381B2Production and use of novel peptide-based agents for use with bi-specific antibodiesIMMUNOMEDICS INC·Filed 2005·Granted Sep 30, 2008·14 cites·51 claims
- 1389US9371396B2Anti-CD22 anti-idiotypic antibodies and uses thereofSINOMAB BIOSCIENCE LTD·Filed 2013·Granted Jun 21, 2016·8 cites·2 claims
- 1488US6730300B2Humanization of an anti-carcinoembryonic antigen anti-idiotype antibody and use as a tumor vaccine and for targeting applicationsIMMUNOMEDICS INC·Filed 1997·Granted May 4, 2004·61 cites·12 claims
- 1585US7052872B1Bi-specific antibodies for pre-targeting diagnosis and therapyIMMUNOMEDICS INC·Filed 1999·Granted May 30, 2006·49 cites·13 claims
- 1681US6090381AStimulation of an immune response with antibodies labeled with the . .alpha-galactosyl epitopeIMMUNOMEDICS INC·Filed 1998·Granted Jul 18, 2000·46 cites·6 claims
- 1780US7666415B2Production and use of novel peptide-based agents for use with bi-specific antibodiesIMMUNOMEDICS INC·Filed 2009·Granted Feb 23, 2010·1 cites·34 claims
- 1879US7563439B2Production and use of novel peptide-based agents for use with bi-specific antibodiesIMMUNOMEDICS INC·Filed 2007·Granted Jul 21, 2009·1 cites·13 claims
- 1977US2025136683A1Method of modulating autoimmunity by disrupting cis-ligand binding of siglec type antigensSINOMAB BIOSCIENCE LTD·Filed 2024·Application pending·0 cites
- 2075US6953675B2Landscaped antibodies and antibody fragments for clinical useIMMUNOMEDICS INC·Filed 1998·Granted Oct 11, 2005·43 cites·7 claims
- 2174US7943343B2Production and use of novel peptide-based agents for use with bi-specific antibodiesIMMUNOMEDICS INC·Filed 2009·Granted May 17, 2011·0 cites·20 claims
- 2274US7074405B1Use of bi-specific antibodies for pre-targeting diagnosis and therapyIMMUNOMEDICS INC·Filed 1999·Granted Jul 11, 2006·61 cites·13 claims
- 2373US12173065B2Fusion proteins comprising extracellular domain of human CD22SINOMAB BIOSCIENCE LTD·Filed 2019·Granted Dec 24, 2024·0 cites·12 claims
- 2471US2010015048A1Internalizing Anti-CD74 Antibodies and Methods of UseIMMUNOMEDICS INC·Filed 2009·Application pending·0 cites
- 2570US8771694B2Immunoconjugates and humanized antibodies specific for B-cell lymphoma and leukemia cellsLEUNG SHUI-ON·Filed 2001·Granted Jul 8, 2014·5 cites·3 claims
- 2668US2005106108A1Immunoconjugates and humanized antibodies specific for B-cell lymphoma and leukemia cellsIMMUNOMEDICS INC·Filed 2004·Application pending·0 cites
- 2766US2024409647A1Bispecific binding proteins against alarmins and uses thereofSINOMAB BIOSCIENCE LTD·Filed 2024·Application pending·0 cites
- 2865US7348419B2Humanization of an anti-carcinoembryonic antigen anti-idiotype antibody as a tumor vaccine and for targeting applicationsIMMUNOMEDICS INC·Filed 2004·Granted Mar 25, 2008·0 cites·9 claims
- 2965US2004013607A1Immunoconjugates and humanized antibodies specific for B-cell lymphoma and leukemia cellsIMMUNOMEDICS INC·Filed 2003·Application pending·0 cites
- 3065US2007172920A1Immunoconjugates and humanized antibodies specific for b-cell lymphoma and leukemia cellsIMMUNOMEDICS INC·Filed 2007·Application pending·0 cites
- 3164US2004258682A1Gylocosylated humanized B-cell specific antibodiesIMMUNOMEDICS INC·Filed 2004·Application pending·0 cites
- 3264US2025282852A1Methods of treating neurological diseasesSINOMAB BIOSCIENCE LTD·Filed 2023·Application pending·0 cites
- 3361US7413736B2Humanization of an anti-carcinoembryonic antigen anti-idiotype antibody as a tumor vaccine and for targeting applicationsIMMUNOMEDICS INC·Filed 2007·Granted Aug 19, 2008·0 cites·3 claims
- 3461US2024309089A1Methods of treating neurological diseasesSINOMAB BIOSCIENCE LTD·Filed 2022·Application pending·0 cites
- 3558US2010158803A1Production and Use of Novel Peptide-Based Agents for Use with Bi-Specific AntibodiesIMMUNOMEDICS INC·Filed 2010·Application pending·0 cites
- 3657US10613099B2Cell lines expressing surface bound anti-idiotype antibodies against anti-CD22 antibodies and uses thereofSINOMAB BIOSCIENCE LTD·Filed 2016·Granted Apr 7, 2020·0 cites·14 claims
- 3757US2010284906A1Internalizing Anti-CD74 Antibodies and Methods of UseIMMUNOMEDICS INC·Filed 2010·Application pending·0 cites
- 3857US2024409631A1Aqueous formulations of an anti-cd22 antibody and uses thereofSINOMAB BIOSCIENCE LTD·Filed 2022·Application pending·0 cites
- 3956US2003035800A1Glycosylated humanized B-cell specific antibodiesFiled 2001·Application pending·0 cites
- 4054US2006140858A1Drug pre-targeting by means of bi-specific antibodies and hapten constructs comprising a carrier peptide and the active agent(s)IMMUNOMEDICS INC·Filed 2003·Application pending·0 cites
- 4151US6440386B1Stabilized radiophosphate-labeled proteinsIMMUNOMEDICS INC·Filed 1999·Granted Aug 27, 2002·12 cites·25 claims
- 4251US2002102254A1Immunoconjugates and humanized antibodies specific for B-cell lymphoma and leukemia cellsFiled 2000·Application pending·0 cites
- 4347US2003099629A1Recombinant onconase and chemical conjugates and fusion proteins of recombinant onconaseIMMUNOMEDICS INC·Filed 2002·Application pending·0 cites
- 4447US2002176856A1Stimulation of an immune response with antibodies labeled with the alpha-galactosyl epitopeIMMUNOMEDICS INC·Filed 2002·Application pending·0 cites
- 4546US2010197896A1Functional humanization of complementarity determining regions (cdrs)LEUNG SHUI-ON·Filed 2008·Application pending·0 cites
- 4646US2002076406A1Multivalent target binding proteinFiled 2001·Application pending·0 cites
- 4746US2010137156A1Construction and use of a functionally human antibody library with maximized repertoire diversityLEUNG SHUI-ON·Filed 2008·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Shui-On Leung files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →